11/25
05:00 pm
cgem
Form 4 Cullinan Therapeutics, For: Nov 24 Filed by: Michaelson Jennifer
Low
Report
Form 4 Cullinan Therapeutics, For: Nov 24 Filed by: Michaelson Jennifer
11/24
04:28 pm
cgem
Form 144 Cullinan Therapeutics, Filed by: Michaelson Jennifer
Medium
Report
Form 144 Cullinan Therapeutics, Filed by: Michaelson Jennifer
11/21
04:30 pm
cgem
Form 8-K Cullinan Therapeutics, For: Nov 18
High
Report
Form 8-K Cullinan Therapeutics, For: Nov 18
11/14
04:06 pm
cgem
Form SCHEDULE 13G/A Cullinan Therapeutics, Filed by: CITADEL ADVISORS LLC
Low
Report
Form SCHEDULE 13G/A Cullinan Therapeutics, Filed by: CITADEL ADVISORS LLC
11/14
02:01 pm
cgem
Form SCHEDULE 13G/A Cullinan Therapeutics, Filed by: Lynx1 Capital Management LP
Low
Report
Form SCHEDULE 13G/A Cullinan Therapeutics, Filed by: Lynx1 Capital Management LP
11/6
07:14 am
cgem
Form 10-Q Cullinan Therapeutics, For: Sep 30
Low
Report
Form 10-Q Cullinan Therapeutics, For: Sep 30
11/6
07:03 am
cgem
Form 8-K Cullinan Therapeutics, For: Nov 06
Low
Report
Form 8-K Cullinan Therapeutics, For: Nov 06
11/3
09:14 am
cgem
Form 8-K Cullinan Therapeutics, For: Nov 03
Medium
Report
Form 8-K Cullinan Therapeutics, For: Nov 03
10/30
05:13 pm
cgem
Form 4 Cullinan Therapeutics, For: Oct 28 Filed by: Nichols Weston
High
Report
Form 4 Cullinan Therapeutics, For: Oct 28 Filed by: Nichols Weston
10/30
02:58 pm
cgem
Form SCHEDULE 13G/A Cullinan Therapeutics, Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A Cullinan Therapeutics, Filed by: VANGUARD GROUP INC
10/21
07:00 pm
cgem
Form 4 Cullinan Therapeutics, For: Oct 14 Filed by: Nichols Weston
Medium
Report
Form 4 Cullinan Therapeutics, For: Oct 14 Filed by: Nichols Weston
10/10
06:59 pm
cgem
Form 4 Cullinan Therapeutics, For: Oct 08 Filed by: Nichols Weston
Medium
Report
Form 4 Cullinan Therapeutics, For: Oct 08 Filed by: Nichols Weston
10/10
06:57 pm
cgem
Form 3 Cullinan Therapeutics, For: Oct 08 Filed by: Nichols Weston
High
Report
Form 3 Cullinan Therapeutics, For: Oct 08 Filed by: Nichols Weston
10/10
06:53 pm
cgem
Form SCHEDULE 13G/A Cullinan Therapeutics, Filed by: Lynx1 Capital Management LP
High
Report
Form SCHEDULE 13G/A Cullinan Therapeutics, Filed by: Lynx1 Capital Management LP